Clinical trial
Phase II Study of Combined Oxaliplatin and Paclitaxel for Metastatic Germ Cell Tumors
NCT00611962 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of Combined Oxaliplatin and Paclitaxel for Metastatic Germ Cell Tumors
- Lead sponsor
- Sanofi
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2000
- Completion date
- March 31, 2004
- Enrollment
- 27 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.